Claim(permalink)
U.S. President Donald Trump will benefit financially if hydroxychloroquine becomes an established treatment for COVID-19.
Factors
veracity
Political Leaning
Sentiment
Date published
2020-04-07
Entities
MarsStrictly SpeakingJustice of the peaceNovartisThe TimesPharmaceutical industryFamily of Donald TrumpFrench languageHydroxychloroquineThe New York TimesFood and Drug AdministrationUnited StatesPresident of the United StatesDonald TrumpISharesMarketWatchGeneric drugFinancial analystMorgan Motor CompanySanofiInvestment banking

